ES443982A1 - Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos. - Google Patents

Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos.

Info

Publication number
ES443982A1
ES443982A1 ES443982A ES443982A ES443982A1 ES 443982 A1 ES443982 A1 ES 443982A1 ES 443982 A ES443982 A ES 443982A ES 443982 A ES443982 A ES 443982A ES 443982 A1 ES443982 A1 ES 443982A1
Authority
ES
Spain
Prior art keywords
gamma globulins
gamma
process reducing
anticomplementary activity
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES443982A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RATIOPHARMA ANSTALT
Original Assignee
RATIOPHARMA ANSTALT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RATIOPHARMA ANSTALT filed Critical RATIOPHARMA ANSTALT
Publication of ES443982A1 publication Critical patent/ES443982A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES443982A 1975-01-02 1975-12-30 Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos. Expired ES443982A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (1)

Publication Number Publication Date
ES443982A1 true ES443982A1 (es) 1977-07-16

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
ES443982A Expired ES443982A1 (es) 1975-01-02 1975-12-30 Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos.

Country Status (20)

Country Link
JP (1) JPS5512001B2 (xx)
AT (1) AT344883B (xx)
AU (1) AU505416B2 (xx)
BE (1) BE837211A (xx)
CA (1) CA1058075A (xx)
DD (1) DD121875A5 (xx)
DE (1) DE2500076C3 (xx)
DK (1) DK144679C (xx)
EG (1) EG11987A (xx)
ES (1) ES443982A1 (xx)
FR (1) FR2296429A1 (xx)
GB (1) GB1495159A (xx)
IE (1) IE43449B1 (xx)
IL (1) IL48766A (xx)
IN (1) IN143525B (xx)
NL (1) NL179824C (xx)
PL (1) PL99599B1 (xx)
SE (1) SE437470B (xx)
SU (1) SU576898A3 (xx)
ZA (1) ZA758050B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
DE3271181D1 (en) * 1982-02-08 1986-06-19 Schweiz Serum & Impfinst Intravenously administrable human immunoglobuline and process for its preparation
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
US8497072B2 (en) 2005-11-30 2013-07-30 Abbott Laboratories Amyloid-beta globulomer antibodies
PL2289909T3 (pl) 2005-11-30 2015-04-30 Abbvie Inc Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
CA2808187A1 (en) 2010-08-14 2012-02-23 Abbvie Inc. Amyloid-beta binding proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (xx) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (xx) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
AT344883B (de) 1978-08-10
JPS5512001B2 (en) 1980-03-29
DE2500076B2 (de) 1979-02-22
FR2296429A1 (fr) 1976-07-30
AU8792175A (en) 1977-07-14
ZA758050B (en) 1976-12-29
IL48766A (en) 1979-11-30
GB1495159A (en) 1977-12-14
NL179824C (nl) 1986-11-17
AU505416B2 (en) 1979-11-22
DK144679B (da) 1982-05-10
SE7514388L (sv) 1976-07-05
BE837211A (fr) 1976-06-30
IN143525B (xx) 1977-12-17
EG11987A (en) 1981-12-31
JPS5191321A (en) 1976-08-10
NL7514627A (nl) 1976-07-06
DK144679C (da) 1982-10-11
SU576898A3 (ru) 1977-10-15
FR2296429B1 (xx) 1978-12-01
IE43449B1 (en) 1981-02-25
IL48766A0 (en) 1976-02-29
PL99599B1 (pl) 1978-07-31
DE2500076A1 (de) 1976-07-08
CA1058075A (en) 1979-07-10
IE43449L (en) 1976-07-02
DK584375A (da) 1976-07-03
ATA981675A (de) 1977-12-15
DE2500076C3 (de) 1982-11-18
DD121875A5 (xx) 1976-09-05
NL179824B (nl) 1986-06-16
SE437470B (sv) 1985-03-04

Similar Documents

Publication Publication Date Title
ES443982A1 (es) Un procedimiento para elevar la tolerancia intravenosa de globulinas gamma precipitadas de la sangre o de productos sanguineos.
NO820226L (no) Fremgangsmaate for fremstilling av alkaliopploeselig cellulosederivat
FR2302136A1 (fr) Procede perfectionne de traitement du ble en milieu aqueux
ES395315A1 (es) Procedimiento para la separacion de proteinas a partir de pescado.
NL7613185A (nl) Werkwijze ter bereiding van cellulose-oplossing, alsmede onder toepassing daarvan vervaardigde voortbrengselen.
AT268189B (de) Verfahren zur Aldehydbehandlung (Formlisierung) von Zellulose, Zelluloseestern oder Stärke
IT1040118B (it) Ricupero mediante coagulazione di resine di polisolfoni dalo ro soluzioni
GB1062434A (en) Process for isolating -antitrypsin
ES408273A1 (es) Procedimiento para la preparacion de 4-cloro-2,5-dimetoxi-anilina.
SE7504794L (sv) Forfarande for framstellning av cyanursyra
GB1352613A (en) Stabilized agar product and method for its stabilization
FR2041806A7 (en) Herbicidal haloacrylic acids
GB1313921A (en) Process for preparation of sterile lecithin
GB1011013A (en) Disaggregated gamma globulin and process for preparing it
CA918073A (en) Process for purifying solutions of the foot-and-mouth disease virus
CH554350A (de) Verfahren zur herstellung von n-substituierten, symmetrischen dihydrotriazin-derivaten.
ES316658A1 (es) Procedimiento de preparacion de fosfotungstenato amonico como intercambiador cationico.
ES445395A1 (es) Un procedimiento de preparacion de 1-o-acetoxibenzoil-4-hi- droxi-l'prolina y 1-o-acetoxibenzoil-l-prolina.
SU704621A1 (ru) Способ лечени нарушений функционального состо ни печени при синдроме массивных трансфузий крови
ES376582A1 (es) Procedimiento de obtencion de una sal del cloranfenicol.
ES378065A1 (es) Procedimiento para la obtencion de la sal n-epsilon-aceta- mido - caproato de l-lisina.
ES452632A1 (es) Procedimiento para la obtencion del bis(p-clorofenoxiisobu- tirato) de hidroxialuminio.
CH558380A (de) Verfahren zur herstellung von 1-(1,3,4-thiadiazol-2-yl)imidazoldinon-(2)-derivaten.
ES426714A1 (es) Procedimiento para refinar una solucion acuosa de tiociana- to.
ES396028A1 (es) Procedimiento de obtencion de palmitato de fluracepan.